Periodic Reporting for period 2 - DABAT (DNA-sensing by AIM2 in activated B cells: novel targets to improve allogeneic haematopoietic stem cell transplantation)

Allogeneic haematopoietic cell transplantation (allo-HCT) is the standard therapy for several haematological cancers and diseases, with more than 30,000 allo-HCTs carried out annually worldwide. In allo-HCT, the recipient receives a new immune system to correct an immune...